Scarica l'app Stockscreener
0.7225
4.30%
-0.0325
Talphera Inc Borsa (TLPH) Ultime notizie
Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023) - Yahoo Finance
Talphera (FRA:R5XA) Inventories, Raw Materials & Components : €0.00 Mil (As of Jun. 2024) - GuruFocus.com
Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges - Yahoo Finance
Talphera: Q3 Earnings Snapshot - mySA
Talphera Reports Q3 2024 Results and Study Progress - TipRanks
Talphera's Q3 Loss Widens to $3.4M as NEPHRO Trial Expands to New Sites | TLPH Stock News - StockTitan
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire
An Overview of Talphera's Earnings - Benzinga
Talphera Sets Q3 2024 Earnings Call for November 13Key Financial Results Update | TLPH Stock News - StockTitan
Talphera, Inc. (NASDAQ:TLPH) Sees Large Decline in Short Interest - Defense World
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - Citizentribune
Talphera extends agreement deadline with Nantahala Management By Investing.com - Investing.com Australia
Talphera extends agreement deadline with Nantahala Management - Investing.com
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald
Talphera CEO Vincent J. Angotti buys $7.6k in company stock - Investing.com
Credit Suisse gives an Underperform recommendation for Talphera Inc. (TLPH) - Knox Daily
TLPH Stock Earnings: Talphera Beats EPS for Q2 2024 - MSN
Talphera starts key trial for anticoagulant nafamostat - Investing.com India
Talphera starts key trial for anticoagulant nafamostat By Investing.com - Investing.com Canada
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit - PR Newswire
Talphera First Half 2024 Earnings: US$0.31 loss per share (vs US$0.40 loss in 1H 2023) - Yahoo Finance
Talphera Inc (TLPH) Q2 2024 Earnings Call Transcript Highlights: Strategic Advancements and Financial Adjustments - GuruFocus.com
Talphera: Q2 Earnings Snapshot - San Antonio Express-News
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update - Longview News-Journal
Talphera, Inc. (NASDAQ:TLPH) Q2 2024 Earnings Call Transcript - MSN
Talphera Announces CMO Retirement and Successor Appointment - TipRanks
Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire
Comparing Talphera (NASDAQ:TLPH) and Altimmune (NASDAQ:ALT) - Defense World
Talphera (TLPH) to Release Earnings on Wednesday - Defense World
Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024 - Longview News-Journal
Talphera, Inc. (NASDAQ:TLPH) Short Interest Down 20.8% in July - Defense World
TLPH (Talphera) Cash-to-Debt : No Debt - GuruFocus.com
Short Interest in Talphera, Inc. (NASDAQ:TLPH) Drops By 16.9% - Defense World
Talphera secures shareholder nod for executive compensation plans By Investing.com - Investing.com India
Talphera Shareholders Affirm Leadership and Financial Strategy - TipRanks
Atlassian's president sells shares worth $121600 By Investing.com - Investing.com
UCB shares target raised on strong product launches, rated Overweight By Investing.com - Investing.com Australia
Talphera Inc. [TLPH] Investment Guide: What You Need to Know – Knox Daily - Knox Daily
Quarterly Snapshot: Quick and Current Ratios for Talphera Inc. (TLPH) – DWinneX - The Dwinnex
Talphera Inc. (TLPH) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Talphera CEO Angotti buys shares worth $9856 By Investing.com - Investing.com Canada
Talphera CEO Angotti buys shares worth $9856 - Investing.com India
0.83%
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):